Antibodies, Behavior and Cognition: Rethinking Immune Privilege

RockefellerUniversity's picture

Event Details

Betty Diamond, M.D., professor and head, Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institute for Medical Research

Kathleen Gaffney

Reception, 7:45 p.m. - 8:00 p.m., Abby Lounge

Add To Your Calendar

Related News

In the fight against viral infection, spelling counts

For millions of years, humans and viruses have engaged in a constant tug of war: as our cells evolve new ways to defend us from our viral enemies, these pathogens in turn acquire new traits to sidestep those defenses. Now, scientists have found that a key similarity between our genes…...

Targeting a single protein might treat a broad range of viruses

Most drugs that fight viruses are designed to target individual pathogens. But scientists at The Rockefeller University have identified a protein that a broad range of viruses require to spread within a host—a discovery that could lead to fighting viruses as varied as parainfluenza, West Nile, and Zika with a…...

Potential new treatment for Fragile X targets one gene to affect many

In Fragile X Syndrome—the leading genetic form of intellectual disability and autism—the effects of a single defective gene ripple through a series of chemical pathways, altering signals between brain cells. It’s a complex condition, but new research from Rockefeller University finds that inhibiting a regulatory protein alters the intricate signaling…...

Copy this html code to your website/blog to embed this press release.


Post new comment

3 + 15 =

To prevent automated spam submissions leave this field empty.